Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma

MeSH terms

• Adult
• Aged
• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use*
• Benzamides
• Disease Progression
• Female
• Humans
• Imatinib Mesylate
• Male
• Mesothelioma / drug therapy*
• Middle Aged
• Pilot Projects
• Piperazines / adverse effects
• Piperazines / therapeutic use*
• Pleural Neoplasms / drug therapy*
• Protein Kinase Inhibitors / adverse effects
• Protein Kinase Inhibitors / therapeutic use*
• Pyrimidines / adverse effects
• Pyrimidines / therapeutic use*
• Receptors, Platelet-Derived Growth Factor / drug effects
• Stem Cell Factor / metabolism
• Treatment Failure